
The Battle for Germany’s Medical Cannabis Market: Who’s Fighting for What
Today, (Wednesday, January 14), a public hearing will bring together 22 hand-picked experts for a debate on the future country’s

Today, (Wednesday, January 14), a public hearing will bring together 22 hand-picked experts for a debate on the future country’s

As Trump’s rescheduling executive order dominated the cannabis industry’s attention over the holiday period, Germany’s controversial medical cannabis bill quietly

Since Germany’s Cannabis Act (CanG) came into force on 1 April 2024, much has changed regarding what was once the

Since April 2024, Germany has been firmly cemented at the centre of the global cannabis conversation, and for good reason.

Parts of the German federal government are dissatisfied with the current interpretation of the Cannabis Act (CanG), introduced by the

This article is also available in German Germany’s new Federal Drug Commissioner, Prof Dr Hendrik Streeck (CDU), who in June

Over the past few years, telemedicine has reshaped how patients access medical cannabis, launching a wave of digital clinics across

Some see Poland’s telemedicine crackdown as a cautionary tale, others see its subsequent rebound as a beacon of hope. Regardless, it now appears to be the new reality for developing medical cannabis markets.

Germany’s Ministry of Health has now published a long-feared draft amendment to its Medical Cannabis Act (MedCanG), threatening a crackdown which will be a major cause for concern for hundreds of cannabis businesses, both in and outside of German borders.

It is not clear how the new Drugs Commissioner will react to the blistering growth of telemedicine, but it is clear that patients would suffer most should access be tightened.
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.